Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Katrin Wetzko"'
Autor:
Ignacio I Wistuba, Mamta Kalra, Linus Backert, Martin Wermke, Edwin R Parra, Jason John Luke, Apostolia M Tsimberidou, Sebastian Bunk, Mohammad B Hossain, Andrea Mayer-Mokler, Arun Satelli, Norbert Hilf, Steffen Walter, Cedrik M Britten, Van K Morris, Tobias A W Holderried, Winfried H Alsdorf, Katrin Wetzko, Borje S Andersson, Sandra Grund-Gröschke, Katrin Aslan, Anantha Marisetty, Swapna Satam, Jens Hukelmann, M Alper Kursunel, Karine Pozo, Andreas Acs, Melissa Baumeister, Claudia Wagner, Oliver Schoor, Ali S Mohamed, Delfi Krishna
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Rationale of the trial Although the use of engineered T cells in cancer immunotherapy has greatly advanced the treatment of hematological malignancies, reaching meaningful clinical responses in the treatment of solid tumors is still challenging. We i
Externí odkaz:
https://doaj.org/article/6a562891133f4ee084b42c34b2d77b3e
Autor:
Stephane Champiat, Martin Wermke, Johann de Bono, Aurelien Marabelle, Christiane Jungels, Cécile Vicier, Norbert Vey, Catrin List, Katrin Wetzko, Leo Ruhnke, Elena Garralda, Vladimir Galvão de Aguiar, Patricia LoRusso, Nuria Kotecki, Aude De Gassart, Emmanuel Valentin, Patrick Brune, Marina Iché, Céline Leparquier, Daniel Olive, Paul Frohna
Publikováno v:
Cancer Research. 82:CT188-CT188
Background: γ9δ2 T cells are part of the innate-like immune response to malignancies and have the ability to bridge to the adaptive immune response via cytokine release (e.g., IFNγ and TNFα). Butyrophilin 3A is a novel checkpoint molecule require
Autor:
Aurélien Marabelle, Stéphane Champiat, Katrin Wetzko, Catrin List, Cecile Vicier, Paul Frohna, Christiane Jungels, Leo Rhunke, Patricia LoRusso, Steven Le Gouill, Vladimir Galvaö de Aguiar, Marina Iche, Elena Garralda, Norbert Vey, Emmanuel Valentin, Daniel Olive, Aude De Gassart, Johann S. de Bono, Martin Wermke, Patrick Brune
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A535-A535
BackgroundWe presented EVICTION Trial data from patients with solid tumors that showed microgram doses of ICT01 rapidly activate γ9δ2 T cells that release inflammatory cytokines (e.g., IFNγ) and traffic from the circulation (Abstract #316, SITC 20
Autor:
Frank Kroschinsky, Falk Heidenreich, Gero Hütter, H. Schmidt, Rainer Ordemann, Malte von Bonin, Maria Schmiedgen, Katharina Heidrich, Martin Bornhäuser, Anke Fuchs, Uta Oelschlägel, Michael Kramer, Johannes Schetelig, Elke Rücker-Braun, Kristina Hölig, Katrin Wetzko, Raphael Teipel, Gerhard Ehninger
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(11)
This study was conducted to characterize and compare peripheral blood stem cell grafts from healthy donors who underwent granulocyte colony-stimulating factor (G-CSF) mobilization and subsequently received 1 dose of plerixafor after insufficient stem
Autor:
Katrin Wetzko, Uwe Platzbecker
Publikováno v:
Hematology/oncology clinics of North America. 28(6)
Myelodysplastic syndromes are one of the most common hematological disorders in the elderly. Therefore, an increase in the prevalence of de novo but also of secondary forms after prior chemotherapy or radiotherapy, respectively, is anticipated within
Autor:
B. Schulte-Hubbert, Matthias Blechschmidt, Frank Kroschinsky, S. Ganepola, Kristina Hölig, G. Ehninger, Katrin Wetzko, Michael Laniado, Markus K. Schuler, D. Braumann, Rainer Ordemann, K. Poppe-Thiede, R. Fischbach, L. Cotta
Publikováno v:
Transfusion Medicine. 23:69-71
Autor:
Ralph Naumann, Diana Kluge, Annette Haenel, Katrin Wetzko, Nadja Friedel, Helmuth Schmidt, Monic Dawel, Bettina Beuthien-Baumann, Uta Schwanebeck, Rainer Ordemann, Mathias Haenel, Gerhard Ehninger
Publikováno v:
Blood. 116:1754-1754
Abstract 1754 Introduction: The development of the escalated BEACOPP regimen let to an improved outcome in patients with advanced Hodgkin‘s lymphoma (HD9 study of the GHSG). However, the application of high dose etoposide (cumulative 4,8 g/m2 per 8
Autor:
Ralph Naumann, Gerhard Ehninger, Mathias Haenel, Bettina Beuthien-Baumann, Kai Friedrichsen, Annette Haenel, H. Schmidt, Ernst Zschuppe, Katrin Wetzko, Monic Dawel, Uta Schwanebeck
Publikováno v:
ASH 49th Annual Meeting, 08.-11.12.2007, Atlanta/Georgia, USA
BLOOD 110(2007)11, 685A
BLOOD 110(2007)11, 685A
Introduction: The development of the escalated BEACOPP regimen let to an improved outcome in patients with advanced Hodgkin Lymphoma (HD9 study of the GHSG). However, the application of high dose etoposide (cumulative 4,8 g/m2 per 8 cycles) seems to